Won H. Lee

Ulsan, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

DRG2 levels in prostate cancer cell lines predict response to PARP inhibitor during docetaxel treatment.

DRG2 levels in prostate cancer cell lines predict response to PARP inhibitor during docetaxel treatment.

Journal: Investigative and clinical urology

Published: July 30, 2024

Enhancer of zeste homolog 2 (EZH2)-dependent sirtuin-3 determines sensitivity to glucose starvation in radioresistant head and neck cancer cells.

Enhancer of zeste homolog 2 (EZH2)-dependent sirtuin-3 determines sensitivity to glucose starvation in radioresistant head and neck cancer cells.

Journal: Cellular signalling

Published: September 08, 2023

Docetaxel Enhances Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Mediated Apoptosis in Prostate Cancer Cells via Epigenetic Gene Regulation by Enhancer of Zeste Homolog 2.

Docetaxel Enhances Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Mediated Apoptosis in Prostate Cancer Cells via Epigenetic Gene Regulation by Enhancer of Zeste Homolog 2.

Journal: The world journal of men's health

Published: April 18, 2022

Tristetraprolin regulates phagocytosis through interaction with CD47 in head and neck cancer.

Tristetraprolin regulates phagocytosis through interaction with CD47 in head and neck cancer.

Journal: Experimental and therapeutic medicine

Published: January 18, 2022

Developmentally regulated GTP-binding protein 2 levels in prostate cancer cell lines impact docetaxel-induced apoptosis.

Developmentally regulated GTP-binding protein 2 levels in prostate cancer cell lines impact docetaxel-induced apoptosis.

Journal: Investigative and clinical urology

Published: December 08, 2020

Epigenetic regulation of p62/SQSTM1 overcomes the radioresistance of head and neck cancer cells via autophagy-dependent senescence induction.

Epigenetic regulation of p62/SQSTM1 overcomes the radioresistance of head and neck cancer cells via autophagy-dependent senescence induction.

Journal: Cell death & disease

Published: October 13, 2020

Cerebrospinal fluid type I interferon and cytokine profiles in enteroviral meningitis according to the presence or absence of pleocytosis.

Cerebrospinal fluid type I interferon and cytokine profiles in enteroviral meningitis according to the presence or absence of pleocytosis.

Journal: Pediatrics and neonatology

Published: October 13, 2020

Tristetraprolin Posttranscriptionally Downregulates TRAIL Death Receptors.

Tristetraprolin Posttranscriptionally Downregulates TRAIL Death Receptors.

Journal: Cells

Published: June 24, 2020

The role of CIP2A as a therapeutic target of rapamycin in radioresistant head and neck cancer with TP53 mutation.

The role of CIP2A as a therapeutic target of rapamycin in radioresistant head and neck cancer with TP53 mutation.

Journal: Head & neck

Published: February 08, 2019

EphA3 maintains radioresistance in head and neck cancers through epithelial mesenchymal transition.

EphA3 maintains radioresistance in head and neck cancers through epithelial mesenchymal transition.

Journal: Cellular signalling

Published: December 18, 2017

Development of TRAIL resistance by radiation-induced hypermethylation of DR4 CpG island in recurrent laryngeal squamous cell carcinoma.

Development of TRAIL resistance by radiation-induced hypermethylation of DR4 CpG island in recurrent laryngeal squamous cell carcinoma.

Journal: International journal of radiation oncology, biology, physics

Published: August 13, 2013

Tumor suppressor p53 plays a key role in induction of both tristetraprolin and let-7 in human cancer cells.

Tumor suppressor p53 plays a key role in induction of both tristetraprolin and let-7 in human cancer cells.

Journal: Nucleic acids research

Published: April 19, 2013

Showing 1-12 of 13

Last Updated: 09/26/2026